Clinical trials
Recruiting Dyslipidemias trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Affiliated Hospital of Nantong University | 1 |
| Beijing Tongren Hospital | 1 |
| Central South University | 1 |
| China Medical University, China | 1 |
| Eddingpharm (Zhuhai) Co., Ltd. | 1 |
| First Affiliated Hospital of Fujian Medical University | 1 |
| Hasten Biopharmaceutical Co., Ltd. | 1 |
| Peking University First Hospital | 1 |
| Ruijin Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 14 |
| Diabetes Mellitus | 6 |
| Hypertension | 6 |
| Cardiovascular Diseases | 5 |
| Hypercholesterolemia | 3 |
| Hyperlipoproteinemia Type II | 3 |
| Obesity | 3 |
| Aortic Valve Stenosis | 2 |
| Heart Failure | 2 |
| Homozygous Familial Hypercholesterolemia | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.